We previously reported that human immunodeficiency virus type 2 (HIV-2) carrying alanine or glutamine but not proline at position 120 of the capsid protein (CA) could grow in the presence of anti-viral factor TRIM5α of cynomolgus monkey (CM). To elucidate details of the interaction between the CA and TRIM5α, we generated mutant HIV-2 viruses, each carrying one of the remaining 17 possible amino acid residues, and examined their sensitivity to CM TRIM5α-mediated restriction. Results showed that hydrophobic residues or those with ring structures were associated with sensitivity, while those with small side chains or amide groups conferred resistance. Molecular dynamics simulation study revealed a structural basis for the differential TRIM5α s...
The main objective of this thesis was to define the roles of Gag (p55), in particular, the capsid (C...
The binding of the TRIM5α restriction factor to the HIV capsid is mediated by the C-terminal SPRY do...
HIV-2 differs from HIV-1 in that many infected people experience normal survival, whilst only 20% pr...
Abstract Background Human immunodeficiency virus type 1 (HIV-1) productively infects only humans and...
The tropism of retroviruses relies on their ability to exploit cellular factors for their replicatio...
The tropism of retroviruses relies on their ability to exploit cellular factors for their replicatio...
TRIM5α is an interferon inducible restriction factor which contributes to intrinsic defense against ...
Human immunodeficiency virus (HIV) type 2 shows limited geographical distribution compared with HIV ...
International audienceBACKGROUND: HIV-2, which was transmitted to humans from a distant primate spec...
International audienceBACKGROUND: HIV-2, which was transmitted to humans from a distant primate spec...
International audienceBACKGROUND: HIV-2, which was transmitted to humans from a distant primate spec...
Following retrovirus entry, the viral capsid (CA) disassembles into its component capsid proteins. T...
Human immunodeficiency virus (HIV) type 2 shows limited geographical distribution compared with HIV ...
The TRIM5α protein from rhesus macaques (rhTRIM5α) mediates a potent inhibition of HIV-1 infection v...
Human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus isolated from a macaqu...
The main objective of this thesis was to define the roles of Gag (p55), in particular, the capsid (C...
The binding of the TRIM5α restriction factor to the HIV capsid is mediated by the C-terminal SPRY do...
HIV-2 differs from HIV-1 in that many infected people experience normal survival, whilst only 20% pr...
Abstract Background Human immunodeficiency virus type 1 (HIV-1) productively infects only humans and...
The tropism of retroviruses relies on their ability to exploit cellular factors for their replicatio...
The tropism of retroviruses relies on their ability to exploit cellular factors for their replicatio...
TRIM5α is an interferon inducible restriction factor which contributes to intrinsic defense against ...
Human immunodeficiency virus (HIV) type 2 shows limited geographical distribution compared with HIV ...
International audienceBACKGROUND: HIV-2, which was transmitted to humans from a distant primate spec...
International audienceBACKGROUND: HIV-2, which was transmitted to humans from a distant primate spec...
International audienceBACKGROUND: HIV-2, which was transmitted to humans from a distant primate spec...
Following retrovirus entry, the viral capsid (CA) disassembles into its component capsid proteins. T...
Human immunodeficiency virus (HIV) type 2 shows limited geographical distribution compared with HIV ...
The TRIM5α protein from rhesus macaques (rhTRIM5α) mediates a potent inhibition of HIV-1 infection v...
Human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus isolated from a macaqu...
The main objective of this thesis was to define the roles of Gag (p55), in particular, the capsid (C...
The binding of the TRIM5α restriction factor to the HIV capsid is mediated by the C-terminal SPRY do...
HIV-2 differs from HIV-1 in that many infected people experience normal survival, whilst only 20% pr...